UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012612
Receipt number R000014644
Scientific Title Verification of health enhancement and QOL improvement effect by continuous ubiquinol ingestion
Date of disclosure of the study information 2014/11/01
Last modified on 2018/05/23 14:48:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification of health enhancement and QOL improvement effect by continuous ubiquinol ingestion

Acronym

QH Island Project

Scientific Title

Verification of health enhancement and QOL improvement effect by continuous ubiquinol ingestion

Scientific Title:Acronym

QH Island Project

Region

Japan


Condition

Condition

Nothing

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this project is to evaluate the health enhancement and QOL improvement effect by carrying out continuous intake of ubiquinol, and contribute to a local resident's healthy life.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

QOL score (SF-36)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Participants ingest 120 mg of ubiquinol once a day after a meal.
Participants can continue as long as they wish until November of 2017.
A routine health check is given every six months during the study period, at which times new participants can join the study.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Those who live in Kamijima town, Ehime prefecture.
(2) Those whose age at the time of informed consent is 20 and over.
(3) Those who can understand the purpose and the contents of this study, and can agree with participation by letter.

Key exclusion criteria

(1) The presence of allergic response to test foods.
(2) Pregnancy or beast-feeding.
(3) In addition, those who were judged inadequate by investigator.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tetsu Kinoshita

Organization

Institute of Community Life Sciences Co., Ltd.

Division name

Social Epidemiology Institute

Zip code


Address

1383-2 Hiraimachi, Matsuyama-city, Ehime

TEL

089-904-7811

Email

tetsu.prospective@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Tetsu Kinoshita

Organization

Institute of Community Life Sciences Co., Ltd.

Division name

Social Epidemiology Institute

Zip code


Address

1383-2 Hiraimachi, Matsuyama-city, Ehime

TEL

089-904-7811

Homepage URL


Email

tetsu.prospective@gmail.com


Sponsor or person

Institute

Institute of Community Life Sciences Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Kaneka Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 09 Month 30 Day

Date of IRB


Anticipated trial start date

2013 Year 11 Month 17 Day

Last follow-up date

2018 Year 02 Month 28 Day

Date of closure to data entry


Date trial data considered complete

2018 Year 04 Month 30 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 12 Month 17 Day

Last modified on

2018 Year 05 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014644


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name